Mental health outcomes before psychotropic medications: a retrospective case series of one state hospital records from 1945 to 1954.

BACKGROUND: Current outcomes for mental illness are widely regarded as poor. Since the introduction of psychotropic medications in the mid 1950's, previous psychosocial practices were minimized in favor of medication focused treatment. The majority of large U.S. state hospitals have closed with records destroyed or in storage, inaccessible to researchers. This creates barriers to studying and comparing outcomes before and after this shift in treatment practices. AIMS: The study aim was to examine discharge outcomes in relation to length of stay and diagnosis in one U.S. state hospital. METHODS: This case series study examined 5618 medical records of participants admitted to one state hospital from 1945 to 1954, the decade prior to adoption of psychotropic medications. RESULTS: Of the 3332 individuals who left the facility, over half (59.87%) of first episode hospitalizations were discharged within 1 year, and 16.95% were hospitalized for more than 5 years. 46.17% of all admissions were discharged from hospital with no readmission. The most common diagnoses included schizophrenia, other forms of psychosis, and alcoholism. In the decade before the introduction of psychotropic medications, participants were often admitted for a single episode and returned to their homes within several years. CONCLUSIONS: Although limited to one site, findings suggest that discharge outcomes prior to psychotropic medication as a primary treatment for mental illness may be more positive than previously understood.

Resistance of Haemonchus sp. to monepantel and reduced efficacy of a derquantel / abamectin combination confirmed in sheep in NSW, Australia.

Early in 2015, sheep in a summer rainfall area of NSW, Australia, displayed signs of haemonchosis despite treatment with monepantel. A faecal egg count reduction test (FECRT) was performed on yearlings with natural field infections using various anthelmintics. Only a four-way combination drench achieved a reduction in faecal egg count (FEC) greater than 95%. The combination contained abamectin, albendazole, levamisole and closantel. Treatments with a derquantel/abamectin combination, monepantel and moxidectin reduced FECs by 93, 31, and 30% respectively. Sheep treated with abamectin displayed an increase in FEC of 22%. Larval differentiation counts conducted 10days post-treatment showed that 100% of survivors were Haemonchus sp. This result confirms for the first time monepantel resistant Haemonchus in sheep in NSW, and is amongst the first of the Australian cases in sheep not associated with goats. A second FECRT was performed using sheep from the moxidectin and abamectin treatment groups in the first FECRT. In this second FECRT, monepantel treatment reduced FECs by 51% and 29% in the sheep previously treated with moxidectin and abamectin respectively. This suggests monepantel, in combination with moxidectin, may give some control against severely abamectin resistant Haemonchus.

A survey of Penstemon's genome size.

Penstemon is the largest genus in North America with more than 270 reported species. However, little is known about its genome size. This information may be useful in developing hybrids for landscape use and for gaining insight into its current taxonomy. Using flow cytometry, we estimated the genome size of approximately 40% of the genus (115 accessions from 105 different species). Genome sizes for both reported and probable diploids range from P. dissectus 2C = 0.94 pg (1C = 462 Mbp) to P. pachyphyllus var. mucronatus 2C = 1.88 pg (1C = 919 Mbp), and the polyploids range from P. attenuatus var. attenuatus 2C = 2.35 pg (1C = 1148 Mbp) to P. digitalis 2C = 6.45 pg (1C = 3152 Mbp). Chromosome counts were done for ten previously published and four previously unreported Penstemon species (P. dissectus, P. navajoa, P. caespitosus var. desertipicti, and P. ramaleyi). These counts were compiled with all previously published chromosome data and compared with the flow cytometry results. Ploidy within this study ranged from diploid to dodecaploid. These data were compared and contrasted with the current taxonomy of Penstemon and previously published internal transcribed spacer and chloroplast DNA phylogenetic work. Based on genome size and previous studies, reassigning P. montanus to the subgenus Penstemon and P. personatus to the subgenus Dasanthera, would better reflect the phylogeny of the genus. Furthermore, our data concur with previous studies suggesting that the subgenus Habroanthus be included in the subgenus Penstemon. The DNA content of subgenus Penstemon exhibits high plasticity and spans a sixfold increase from the smallest to the largest genome (P. linarioides subsp. sileri and P. digitalis, respectively). Our study found flow cytometry to be useful in species identification and verification.

A convenient method for synthesis of cyclic peptide libraries.

Cyclic peptides have been reported to bind to multiple, unrelated classes of receptor with high affinity. Owing to the robustness of amide bond chemistry, the ability to explore extensive chemical diversity by incorporation of unnatural and natural amino acids, and the ability to explore conformational diversity, through the incorporation of various constraints, arrays of cyclic peptides can be tailored to broadly sample chemical diversity. We describe the combination of a safety catch linker with a directed-sorted procedure for the synthesis of large arrays of diverse cyclic peptides for high-throughput screening.